Robert W. Kaminski - Concepedia

Author

Robert W. Kaminski

Walter Reed Army Institute of Research ORCID

Also Known As

Kaminski, Robert W., R W Kaminski, R. Kaminski, R. W. Kaminski, R.W. Kaminski, Robert W. Kaminski, Robert Kaminski, Robert W Kaminski, Robert W. Kaminski

Publications

Citations

H-Index

Concepts

All Affiliations

Walter Reed Army Institute of Research Naval Medical Research Command Program for Appropriate Technology in Health Johns Hopkins University Henry M. Jackson Foundation

About

Robert W. Kaminski is an author at Walter Reed Army Institute of Research specializing in medicine, immunology, and vaccination.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	17	21	1K
2	Allergy	3	3	131
3	Health Sciences	1	1	31
4	Public Health	1	1	12
5	Biomedical Engineering	1	1	181

Robert W. Kaminski

Publications

1.8K

Citations

H-Index

Page 1

	Year	Citations
IpaD Localizes to the Tip of the Type III Secretion System Needle of <i>Shigella flexneri</i> Marianela Espina, Andrew J. Olive, Roma Kenjale, Infection and Immunity Shigella FlexneriProtein SecretionSurface LocalizationVirulence FactorPathogenesis	2006	181
Safety and Immunogenicity of a Candidate Bioconjugate Vaccine against Shigella flexneri 2a Administered to Healthy Adults: a Single-Blind, Randomized Phase I Study Mark S. Riddle, Robert W. Kaminski, Claudio Di Paolo, Clinical and Vaccine Immunology	2016	140
Antibodies with specificity to native gp120 and neutralization activity against primary human immunodeficiency virus type 1 isolates elicited by immunization with oligomeric gp160 Thomas C. VanCott, John R. Mascola, Robert W. Kaminski, Journal of Virology ImmunologyAntigen ProcessingImmunotherapyPrimary Hiv-1 IsolatesNeutralization Activity	1997	112
HIV-1 Neutralizing Antibodies in the Genital and Respiratory Tracts of Mice Intranasally Immunized with Oligomeric gp160 Thomas C. VanCott, Robert W. Kaminski, John R. Mascola, The Journal of Immunology Candidate Hiv-1 VaccineImmunologyImmunodominanceImmunotherapyHuman Retrovirus	1998	111
Intransal or intragastric immunization with proteosome-Shigella lipopolysaccharide vaccines protects against lethal pneumonia in a murine model of Shigella infection Corey P. Mallett, Thomas L. Hale, Robert W. Kaminski, Infection and Immunity VaccinationShigella InfectionPulmonary MucosaMucosal VaccinationLethal Pneumonia	1995	80
Safety and immunogenicity of an intranasal Shigella flexneri 2a Invaplex 50 vaccine Mark S. Riddle, Robert W. Kaminski, Carlos Williams, Vaccine VaccinationVaccine DevelopmentMedicineImmunologyIntranasal Shigella	2011	79
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection Kawsar R. Talaat, Cristina Alaimo, Patricia Martín, EBioMedicine	2021	78
Proteosomes, Emulsomes, and Cholera Toxin B Improve Nasal Immunogenicity of Human Immunodeficiency Virus gp160 in Mice: Induction of Serum, Intestinal, Vaginal, and Lung IgA and IgG George H. Lowell, Robert W. Kaminski, Thomas C. VanCott, The Journal of Infectious Diseases	1997	68
Efficacy, safety, and immunogenicity of the Shigella sonnei 1790GAHB GMMA candidate vaccine: Results from a phase 2b randomized, placebo-controlled challenge study in adults Robert W. Frenck, Valentino Conti, Pietro Ferruzzi, EClinicalMedicine	2021	62
Intranasal and intramuscular proteosome-staphylococcal enterotoxin B (SEB) toxoid vaccines: immunogenicity and efficacy against lethal SEB intoxication in mice George H. Lowell, Robert W. Kaminski, Stephen J. Grate, Infection and Immunity Proteosome VaccinesHumoral ResponseImmunologyImmune RegulationImmunodominance	1996	58

Page 1